EAS Publisher | Optimization of the Treatment of Severe Preeclampsia in the Second Half of Pregnancy

Optimization of the Treatment of Severe Preeclampsia in the Second Half of Pregnancy

DOI : https://doi.org/10.36349/EASMS.2020.v03i07.003

937 Downloads 68 Views

The problem of hypertensive disorders during pregnancy, being one of the most serious complications of pregnancy, is still not fully understood. Its frequency in recent years (2009 and later) is 17-24% of the total number of pregnant women and women in labor. The health problem of children born to mothers with preeclampsia remains relevant, since every fourth child with this complication of pregnancy has the effects of hypoxia and stunted growth. This article explores the use of magnesia therapy in pregnant women with severe preeclampsia in the second half of pregnancy. Optimal doses of magnesia therapy and prophylactic measures to prevent eclampsia have been proposed.

TOP EDITORS

Dr. T. Selvankumar
Chief Editor
EAS Journal of Biotechnology and Genetics

Dr. James Kay, PhD
Chief Editor
EAS Journal of Psychology and Behavioural Sciences

Dr. Rejeesh Menon
Chief Editor
EAS Journal of Medicine and Surgery

Dr. S. Jayachandran
Chief Editor
EAS Journal of Dentistry and Oral Medicine

Dr. Md. Habibur Rahman
Chief Editor
EAS Journal of Pharmacy and Pharmacology

Dr. Benard Chemwei, PhD
Chief Editor
East African Scholars Multidisciplinary Bulletin

NFI Joseph Lon
Chief Editor
EAS Journal of Humanities and Cultural Studies

Prof. Dr. Nazir Ahmad Suhail
Chief Editor
East African Scholar Journal of Engineering and Computer Sciences

Dr. Hamid Osman Hamid
Chief Editor
EAS Journals of Radiology and Imaging Technology

Dr. BOUCENNA Mounir
Chief Editor
EAS Journal of Veterinary Medical Science

OPEN ACCESS JOURNALS

Dr. Afroza Begum

Lecturer, Dept. of Pharmacology and Therapeutics, Shaheed Monsur Ali Medical College & Hospital, Uttara, Dhaka-1230, Bangladesh

BEST AUTHOR

Of The Month

TRACK YOUR ARTICLE

Enter the Manuscript Reference Number (MRN)

Get Details